Damian FB, De Melo AC, Dal Molin GZ, Nogueira-Rodrigues A, et al. A phase II trial of palbociclib plus letrozole after progression on second-line chemotherapy for women with hormone receptor-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer (LACOG 1018). Gynecol Oncol 2025;198:161-167.
PMID: 40505182